Skip to content

Models 430-07 & 431-07 Implantable Pacing Leads

by Intermedics, Inc.

510(k) K890412

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK890412 Date28 Mar 1989ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
DTB
Device Class
Class III
Regulation
21 CFR Part 870.3680
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Models 430-07 & 431-07 Implantable Pacing Leads are classified as Permanent Pacemaker Electrodes, designed for cardiac pacing applications. These leads are implanted within the heart to deliver electrical stimulation, facilitating rhythmic cardiac contractions in patients requiring pacing support.

These leads are intended for single-use implantation and are regulated under FDA 510(k) clearance (K890412) with a classification of Class III (DTB). They are supplied sterile and intended for use in clinical settings where cardiac pacing is required, adhering to regulatory standards for cardiovascular devices under regulation number 870.3680.

Other devices from Intermedics, Inc.

See all devices from Intermedics, Inc. →

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • Are these pacing leads designed for reuse in multiple patients, or are they intended for single-use only?

    These leads (Models 430-07 & 431-07) are explicitly intended for single-use implantation only. They are supplied sterile and meant to be used once per patient, adhering to clinical best practices for implantable cardiac devices.

  • What types of storage conditions are recommended for these leads before use?

    While the exact storage instructions aren’t detailed in the provided data, the leads are sterile at time of supply, which implies they should be stored in their original packaging under clean, dry conditions—protected from contamination and extreme temperatures—until ready for use in a sterile clinical environment.

  • How do I identify the correct model for my patient’s needs, and are there multiple sizes or configurations?

    The data doesn’t specify exact sizing or model variations beyond the two listed (430-07 & 431-07), but the product codes (DTB) and FDA clearance (K890412) suggest these are designed for standard permanent pacemaker electrode applications. Clinicians should consult manufacturer documentation or a cardiologist to confirm compatibility with the patient’s anatomy and pacing requirements.

  • What regulatory pathway was followed for FDA clearance, and how does that affect my purchasing decision?

    These leads were cleared via a traditional 510(k) pathway (K890412) with a substantially equivalent (SESE) decision under FDA’s Class III (DTB) classification for permanent pacemaker electrodes. This means they meet FDA standards for safety and effectiveness as determined by the Cardiovascular (CV) Advisory Committee. Purchasers should verify compatibility with their institution’s procurement policies and ensure compliance with local healthcare regulations.